M

Morphic Therapeutic

110 employees

Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics
Medical
drug discovery and immunology

Date founded

2015

Funding rounds raised

Total raised

$80M

from 11 investors over 11 rounds

M

Morphic Therapeutic raised $80M on September 25, 2018

Investors: Omega Funds, shangpharm, Novo Holdings, S.R. One Ltd, The Invus Group and Polaris Partners

M

Morphic Therapeutic raised $52M on June 30, 2016

Investors: Omega Funds, shangpharm, S.R. One Ltd and Polaris Partners

M

Morphic Therapeutic raised $3M on January 1, 2016

Investors: Polaris Partners

FAQ